Radiation rids arteries of re-narrowing for up to five years

May 13, 2002

DALLAS, May 13 - People who received radiation in their arteries during angioplasty had a reduced risk of artery renarrowing for up to five years compared to those who got only angioplasty, according to a report in today's Circulation: Journal of the American Heart Association.

The radiation was given inside the artery to prevent restenosis, a potentially fatal renarrowing of the vessel. Restenosis occurs in about 20 percent of heart patients undergoing procedures such as angioplasty or stenting. Such patients require another procedure or bypass surgery. Stents are metal mesh tubes placed in a blood vessel to prop it open where there is a blockage.

"The important thing we learned from the five-year follow-up of our patients is that radiation therapy is a durable treatment for restenosis," says Paul S. Teirstein, M.D., the study's senior author.

Equally as important, he and his colleagues found no evidence of serious adverse effects caused by the treatment, which used tiny beads of radioactive iridium.

"We didn't see any unwanted swelling of the arteries, any holes in the arteries, or any other unwanted effects of the radiation therapy," says Teirstein, who is director of interventional cardiology at the Scripps Clinic in La Jolla, Calif.

The study involved 55 patients, 26 of whom received radiation and 29 who took a placebo treatment.

Five years later, the researchers found a significant difference between the two groups when they looked at a combination of three outcomes--death from any cause, a nonfatal heart attack, or any procedure to restore the heart's blood flow.

In the placebo group, 86.2 percent had bypass or suffered at least one of the three adverse events compared to 57.7 percent in the radiation group.

"At the beginning of the study, radiation appeared to be a likely candidate to prevent restenosis and beat this cycle of repeat procedures because it had been used in noncoronary cell-proliferation disorders," Teirstein says.

During the procedures, researchers placed a 0.03-inch ribbon containing sealed beads of radioactive iridium in the arteries of one group of patients after their arteries were reopened. This form of radiation treatment is called brachytherapy.

The placebo group received similar ribbons but without the iridium.

Each ribbon was left in the artery for 20 to 45 minutes and then removed.

"This procedure is designed to reduce the need for repeat procedures," Teirstein says. "Over the 5 years, fewer of the radiation patients came back with restenosis compared to the placebo group."

Patients were examined at 6 months, 3 years, and 5 years.

After 6 months, the radiation group had a statistically significant reduction of 74 percent restenosis at the site of their previous narrowing compared to the placebo patients. At 3 years, the reduction was 68 percent and at 5 years, it was 48 percent, both also statistically significant.

The number of patients in the study was small, a fact noted by cardiologist David O. Williams, M.D., in an editorial that accompanies Teirstein's study. Williams is professor of medicine at Brown University School of Medicine in Providence, R.I.

"The very small sample size of this trial limits our ability to be conclusive when interpreting its results," writes Williams. "Nonetheless, it appears that efficacy of brachytherapy was sustained over the period of five years."

"This was a pilot study designed to inspire larger studies, which it did," says Teirstein. "These larger studies have shown significant short-term reductions in restenosis, but not all of them have shown benefit in death and nonfatal heart attacks. Given that we have no other long-term data on this type brachytherapy, which is now used in probably 100,000 patients a year, it is nice to have some information over five years."
Co-authors include Mark A. Grise, M.D.; Vincent Massullo, M.D.; Shirish Jani, Ph.D.; Jeffrey J. Popma, M.D.; Robert J. Russo, M.D., Ph.D.; Richard Schatz, M. D.; Erminia M. Guarneri, M.D.; Stephen Steuterman, M.S.; David A. Cloutier, B. S.; Martin B. Leon, M.D.; and Prabhakar Tripuraneni, M.D.

CONTACT: For journal copies only,
please call: (214) 706-1396
For other information, call:
Carole Bullock: (214) 706-1279
Maggie Francis: (214) 706-1397

American Heart Association

Related Radiation Therapy Articles from Brightsurf:

Pulmonary artery thrombosis a complication of radiation therapy
According to ARRS' American Journal of Roentgenology, the imaging findings of in situ pulmonary artery thrombosis (PAT) associated with radiation therapy (RT) are different from those of acute pulmonary emboli and do not appear to embolize.

New approach for calculating radiation dosimetry allows for individualized therapy
Researchers have developed a simplified process that could enhance personalization of cancer therapy based on a single nuclear medicine scan.

Developing microbeam radiation therapy (MRT) for inoperable cancer
An innovative radiation treatment that could one day be a valuable addition to conventional radiation therapy for inoperable brain and spinal tumors is a step closer, thanks to new research led by University of Saskatchewan (USask) researchers at the Canadian Light Source (CLS).

Travel considerations specified for 177Lu-DOTATATE radiation therapy patients
Researchers and patient advocates have addressed the challenges related to traveling after receiving 177Lu-DOTATATE radiation therapy in a study published in the April issue of The Journal of Nuclear Medicine.

A new way to monitor cancer radiation therapy doses
More than half of all cancer patients undergo radiation therapy and the dose is critical.

AI can jump-start radiation therapy for cancer patients
Artificial intelligence can help cancer patients start their radiation therapy sooner -- and thereby decrease the odds of the cancer spreading -- by instantly translating complex clinical data into an optimal plan of attack.

Towards safer, more effective cancer radiation therapy using X-rays and nanoparticles
X-rays could be tuned to deliver a more effective punch that destroys cancer cells and not harm the body.

Radiation therapy effective against deadly heart rhythm
A single high dose of radiation aimed at the heart significantly reduces episodes of a potentially deadly rapid heart rhythm, according to results of a phase one/two study at Washington University School of Medicine in St.

New mathematical model can improve radiation therapy of brain tumours
Researchers have developed a new model to optimize radiation therapy and significantly increase the number of tumor cells killed during treatment.

Using artificial intelligence to deliver personalized radiation therapy
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to personalize the dose of radiation therapy used to treat cancer patients.

Read More: Radiation Therapy News and Radiation Therapy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.